What is Canakinumab: Uses, Dosage, Side Effects and More

Canakinumab is a prescription medication that helps calm down your immune system when it's overactive. It's specifically designed to block a protein called interleukin-1 beta, which plays a key role in causing inflammation throughout your body.

This medication comes as an injection that you receive under your skin, similar to how people with diabetes give themselves insulin shots. Your doctor will typically prescribe canakinumab when other treatments haven't worked well enough to control certain inflammatory conditions.

What is Canakinumab Used For?

Canakinumab treats several rare but serious conditions where your immune system attacks healthy parts of your body. The medication works particularly well for diseases that involve too much inflammation.

Your doctor might prescribe this medication if you have cryopyrin-associated periodic syndromes, which are genetic conditions that cause repeated episodes of fever and inflammation. These include familial cold autoinflammatory syndrome, Muckle-Wells syndrome, and neonatal-onset multisystem inflammatory disease.

The medication also helps people with systemic juvenile idiopathic arthritis, a type of childhood arthritis that affects the whole body. Additionally, doctors use canakinumab for certain cases of gouty arthritis when other treatments haven't provided enough relief.

In some cases, healthcare providers prescribe canakinumab for Still's disease in adults, tumor necrosis factor receptor-associated periodic syndrome, and hyperimmunoglobulin D syndrome. These are all conditions where inflammation plays a central role in causing symptoms.

How Does Canakinumab Work?

Canakinumab works by blocking interleukin-1 beta, a powerful chemical messenger that tells your body to create inflammation. Think of it as putting a lock on a door that usually lets inflammatory signals pass through.

This medication is considered a strong, targeted therapy rather than a mild treatment. It specifically targets one pathway in your immune system instead of suppressing your entire immune response like some other medications do.

Once canakinumab blocks interleukin-1 beta, the cascade of inflammatory reactions that cause your symptoms begins to calm down. This can lead to reduced fever, less joint pain, and fewer inflammatory flare-ups over time.

The effects of canakinumab can last for several weeks after each injection, which is why you don't need to take it daily like many other medications.

How Should I Take Canakinumab?

Canakinumab comes as a pre-filled syringe or auto-injector that you inject under your skin. Your healthcare provider will teach you the proper injection technique, or a family member can learn to help you.

You'll typically inject the medication into your thigh, upper arm, or abdomen, rotating between different sites each time. The injection site should be at least one inch away from your previous injection spot to prevent irritation.

Before injecting, let the medication sit at room temperature for about 15 to 30 minutes. Cold medication can be more uncomfortable to inject and may not work as effectively.

You don't need to take canakinumab with food since it goes directly under your skin rather than through your digestive system. However, having a light snack beforehand might help if you tend to feel lightheaded during medical procedures.

Always wash your hands thoroughly before handling the injection, and clean the injection site with an alcohol swab. Make sure to dispose of used needles and syringes in a proper sharps container.

How Long Should I Take Canakinumab For?

The length of canakinumab treatment varies significantly depending on your specific condition and how well you respond to the medication. Some people need it for months, while others may require it for several years.

Your doctor will monitor your symptoms and inflammation levels through regular blood tests and check-ups. If the medication is working well and you're not experiencing serious side effects, you might continue treatment long-term.

For conditions like cryopyrin-associated periodic syndromes, you may need ongoing treatment since these are genetic conditions that don't go away on their own. However, for some types of arthritis, your doctor might eventually try reducing the dose or spacing out injections.

Never stop taking canakinumab suddenly without talking to your healthcare provider first. Stopping abruptly could cause your inflammatory symptoms to return quickly and potentially become more severe than before.

What Are the Side Effects of Canakinumab?

Like all medications, canakinumab can cause side effects, though many people tolerate it well. The most common side effects are generally mild and manageable with proper care.

Here are the side effects you're most likely to experience, keeping in mind that your body's response may be different from others:

• Injection site reactions like redness, swelling, or tenderness
• Upper respiratory tract infections such as colds or sinus infections
• Headaches that may occur shortly after injection
• Feeling tired or having less energy than usual
• Muscle or joint aches
• Nausea or stomach discomfort

Most of these common side effects improve on their own within a few days. The injection site reactions typically resolve within 24 to 48 hours.

Some people experience more serious side effects that require immediate medical attention. While these are less common, it's important to know what to watch for:

• Signs of serious infection like persistent fever, chills, or unusual fatigue
• Severe allergic reactions including difficulty breathing or swelling of face and throat
• Unusual bruising or bleeding
• Persistent stomach pain or changes in bowel movements
• New or worsening neurological symptoms

Very rarely, canakinumab may increase your risk of certain cancers or cause severe liver problems. Your doctor will monitor you regularly with blood tests to catch any potential issues early.

Who Should Not Take Canakinumab?

Canakinumab isn't suitable for everyone, and your doctor will carefully evaluate whether it's safe for you. People with active infections should not start this medication until the infection is completely cleared.

You shouldn't take canakinumab if you've had a severe allergic reaction to it before or if you're allergic to any of its ingredients. Your doctor will review your allergy history before prescribing this medication.

People with certain medical conditions need extra caution or may not be able to use canakinumab safely. Let your doctor know if you have any of these conditions:

• Current infections, including tuberculosis or hepatitis
• History of recurring infections or immune system problems
• Recent vaccinations with live vaccines
• Liver or kidney disease
• History of certain cancers
• Inflammatory bowel disease

Pregnant and breastfeeding women should discuss the risks and benefits with their healthcare provider, as there's limited information about canakinumab's safety during pregnancy and nursing.

Canakinumab Brand Names

Canakinumab is available under the brand name Ilaris in most countries, including the United States. This is the primary brand name you'll see on your prescription and medication packaging.

Unlike some medications that have multiple brand names, canakinumab is primarily marketed under this single brand name worldwide. This makes it easier to identify and reduces confusion when traveling or getting prescriptions filled.

When talking to your pharmacist or insurance company, you can refer to the medication by either its generic name "canakinumab" or its brand name "Ilaris." Both names refer to the same medication.

Canakinumab Alternatives

Several other medications work similarly to canakinumab by targeting different parts of the inflammatory process. Your doctor might consider these alternatives if canakinumab isn't suitable for you or stops working effectively.

Anakinra is another interleukin-1 blocker that you inject daily rather than every few weeks. While it works on the same pathway as canakinumab, some people respond better to one than the other.

For certain conditions, your doctor might suggest TNF inhibitors like adalimumab or etanercept. These target a different inflammatory protein called tumor necrosis factor and come in various dosing schedules.

Other options include rilonacept, which blocks interleukin-1 like canakinumab but has a different dosing schedule, and various disease-modifying antirheumatic drugs depending on your specific condition.

The choice between these alternatives depends on your specific diagnosis, how severe your symptoms are, other medications you're taking, and your personal preferences about injection frequency.

Is Canakinumab Better Than Anakinra?

Both canakinumab and anakinra block interleukin-1, but they work slightly differently and have distinct advantages depending on your situation. Neither is universally "better" than the other.

Canakinumab's main advantage is convenience since you only need injections every 4 to 8 weeks compared to anakinra's daily injections. Many people find this less burdensome and easier to stick with long-term.

Anakinra, on the other hand, leaves your system more quickly if you experience side effects. This can be reassuring for people who are nervous about starting a new medication or have had reactions to other treatments.

Some people respond better to one medication than the other, even though they target the same pathway. Your doctor might try anakinra first since it's been available longer and has more research data, or they might start with canakinumab if convenience is a priority.

Cost and insurance coverage can also influence this decision, as the medications have different pricing structures and approval processes with various insurance plans.